Back to Directory
research logo

Cytokinetics | Company Profile - Revenue, Headcount, Tech Stack, Contacts

2/24/2026

Contact Information

πŸ‘€
Cytokinetics
🏒
Cytokinetics
πŸ“
350 Oyster Point Blvd, South San Francisco, California 94080, US

Industry & Market

Primary Industry
research
Location
South San Francisco, California, United States
Public Trading
NASDAQ: CYTK

Company Metrics

πŸ‘₯Total Employees
217
βš™οΈEngineering
19
πŸ’ΌSales Team
7
πŸ“ˆMarketing
19
πŸ“…Founded
1998
πŸ’°Revenue
18.5M
Alexa Ranking#605362

Funding Information

Market Cap
$7.7B
Annual Revenue
$18,474,000
Publicly traded company

Headcount Distribution

Total Employees
217
Departments
19

By Department

Department Breakdown

Operations
Business Development
Engineering
Marketing
Finance
Human Resources
Others

Technology Stack

Analytics & Tracking

Oracle Analytics CloudSalesforce CRM Analytics

Email & Communication

Outlook
Total: 39 technologies

Keywords & Focus Areas

heart failureamyotrophic lateral sclerosishypertrophic cardiomyopathypharmaceuticalslife sciencesbiotechnology: pharmaceutical preparationshealth carebiotechnology researchsarcomere modulationmuscle disease innovationmuscle disease biomarkersmuscle disease diagnosticsservicesmuscle healthmuscle researchcardiologyb2bmuscle performancemuscle energy pathwaysbiotech innovation+10 more
30 total keywords

Cytokinetics

Overview

Cytokinetics is a late-stage biopharmaceutical company based in South San Francisco, California, founded in 1997. The organization specializes in discovering, developing, and commercializing muscle activators and inhibitors to treat cardiovascular and neuromuscular diseases impacting muscle function. With decades of research and innovation in muscle biology, it shifted focus exclusively to this domain in 2008.

The company develops small-molecule drug candidates, including first-in-class muscle activators and next-in-class muscle inhibitors. Its pipeline includes omecamtiv mecarbil, a cardiac myosin activator in Phase III trials for heart failure; aficamten, an oral cardiac myosin inhibitor in Phase III trials for hypertrophic cardiomyopathy; and reldesemtiv, a fast skeletal muscle troponin activator in Phase III trials for amyotrophic lateral sclerosis. Cytokinetics collaborates with Ji Xing Pharmaceuticals to develop and commercialize aficamten in Japan, aiming to enhance muscle strength and performance for patients with muscle-related conditions.

Basic Information

Industryresearch
Founded1998
Revenue18.5M
Headquarters350 Oyster Point Blvd, South San Francisco, California 94080-1912, United States
LanguagesEnglish
Alexa Ranking605362

Contact Details

Key Focus Areas & Initiatives

  • Heart failure
  • Amyotrophic lateral sclerosis
  • Hypertrophic cardiomyopathy
  • Pharmaceuticals
  • Life sciences
  • Biotechnology: pharmaceutical preparations
  • Health care
  • Biotechnology research
  • Sarcomere modulation
  • Muscle disease innovation
  • Muscle disease biomarkers
  • Muscle disease diagnostics
  • Services
  • Muscle health
  • Muscle research
  • Cardiology
  • B2B
  • Muscle performance
  • Muscle energy pathways
  • Biotech innovation
  • Muscle function improvement
  • Regulatory review
  • Muscle function modulation
  • Cardiac muscle
  • Muscle disease treatment
  • Muscle dysfunction therapies
  • Muscle mechanics
  • Muscle contractile mechanism
  • Muscle cell biology
  • Muscle activators
  • Medical research
  • Drug development
  • Muscle therapy
  • Muscle disease management
  • Clinical trials
  • Patents
  • Muscle performance research
  • Scientific innovation
  • Muscle energy transduction
  • Muscle cell signaling
  • Muscle strength enhancement
  • Muscle regeneration
  • Scientific publications
  • Clinical development
  • Muscle performance optimization
  • Neuromuscular diseases
  • Biopharmaceutical
  • Muscle performance enhancement
  • Muscle performance improvement
  • Muscle treatment pipeline
  • Muscle biology research
  • Muscle mechanics drugs
  • Drug discovery
  • Molecular pharmacology
  • Muscle energy metabolism
  • Muscle strength drugs
  • Muscle treatment development
  • Muscle therapy development
  • Patient-centric
  • Muscle disease focus
  • Sarcomere targeting
  • Muscle disease pipeline
  • Muscle disease therapies
  • Late-stage pipeline
  • Muscle treatment
  • Biotechnology
  • Muscle inhibitors
  • Energy metabolism
  • Disease modification
  • Muscle performance drugs
  • Molecular motor proteins
  • Muscle dysfunction
  • Muscle contractile proteins
  • Muscle biology
  • Muscle contractility
  • Muscle disease solutions
  • Muscle cell therapy
  • Muscle disease research
  • Muscle contractility modulation
  • Investigational medicines
  • Muscle strength
  • Muscle protein modulation
  • Pharmaceutical and medicine manufacturing
  • Small molecule drugs
  • Muscle energetics
  • Muscle tissue engineering
  • Therapeutics
  • Clinical research
  • Patient advocacy
  • Cardiac myosin
  • Community engagement
  • Diversity and inclusion
  • Healthspan
  • Debilitating diseases
  • Clinical studies
  • Biopharma
  • Disease management
  • First-in-class medications
  • Medical advancements
  • Ethics in clinical trials
  • Regulatory affairs
  • Corporate responsibility
  • Investor relations
  • Health care professionals
  • Research strategy
  • Drug commercialization
  • Pipeline development
  • Patent portfolio
  • Clinical data
  • Post-doctoral programs
  • Internship programs
  • Community support
  • Public health
  • Biomedical research
  • Healthcare advancements
  • Disease treatment strategies
  • Healthcare
  • Medical
  • Health, wellness & fitness
  • Hospital & health care

Technologies Used

  • AI
  • Act!
  • Amazon Web Services (AWS)
  • Atlassian Cloud
  • Bluekai
  • Concur
  • Create React App
  • DNS Made Easy
  • Drupal
  • GitHub
  • Google AlloyDB for PostgreSQL
  • Google Cloud Machine Learning Engine
  • Google Cloud Platform
  • Greenhouse.io
  • ISO+β„’
  • Microsoft Excel
  • Microsoft Office
  • Microsoft Office 365
  • Mode
  • Oracle Analytics Cloud
  • Outlook
  • Python
  • R
  • Rackspace MailGun
  • Remote
  • SAP Contract Lifecycle Management (CLM)
  • SAS Enterprise Guide
  • SQL
  • Salesforce
  • Salesforce CRM Analytics
  • SharePoint
  • Slack
  • Tableau
  • The Trade Desk
  • Tor
  • Veeva Systems
  • WP Engine
  • Workday
  • Zendesk

Affiliated Organizations & Regional Branches

    Need more information?

    Find decision makers, more insights and contact information about this company on Bitscale

    Start For Free

    Schedule your demo now!

    See how BitScale can supercharge your outbound sales in a 30-minute demo

    Start for Free

    Resources

    Careers

    Pricing

    homeCommunity

    Security

    SayData

    Β© 2026 Bitscale. Featherflow Technology Pvt Ltd.

    LinkedInTwitterInstagramYouTube
    AICPAGDPR
    CCPAISO
    LinkedInTwitterInstagramYouTube